Portuguese
bioterapia Catalan
tractament biològic Treatment of diseases with biological materials or biological response modifiers.
1
TDACs appear to represent an important resource for biotherapy of patients with cancer.
2
Immune monitoring of biotherapy clinical trials has undergone a considerable change in recent years.
3
In conclusion, biotherapy remains an active treatment strategy for initial approach in patients with NETs.
4
After 6 courses of concomitant biochemotherapy, biotherapy was continued in patients who had a clinical benefit.
5
Activated lymphocytes derived from tumor biopsies are very important as a source of biotherapy for cancer.
1
Compared to prior studies, many of these patients resumed or continued biologic therapy.
2
Preoperative immunosuppressive or biologic therapy did not increase the risk of postoperative complications.
3
Future study of Met inhibition as a potential biologic therapy for EA is warranted.
4
We prospectively studied left ventricular function in patients with severe psoriasis who initiated biologic therapy.
5
We analyzed the management of biologic therapy in patients with psoriasis who underwent surgical procedures.
1
We review the recent advances in biological therapy for UC treatment beyond the anti-TNFs.
2
Multivariate analysis indicated that biological therapy and Cohort B were associated with improved mOS.
3
Esophageal squamous cell carcinoma is one of the most chemo- and biological therapy resistant cancers.
4
Lower economic profile and never reading books were both associated with decreased odds of receiving biological therapy.
5
They also cover the topical treatment of psoriasis, photo(chemo)therapy, conventional systemic therapy and biological therapy.
6
Results: After 1 year, 35% of the patients were on biological therapy.
7
Conclusions: We present an update of the SER recommendations for the use of biological therapy in patients with axSpA.
8
Our analysis showed that all analyzed patients' characteristics were significantly associated with biological therapy compared to non-biological systemic one.
9
Background Randomized controlled trials evaluating biological therapy have shown improvements in survival from metastatic colorectal cancer (mCRC).
10
The biological therapy of Crohn's disease, such as infliximab is a powerful approach in the therapy of inflammatory bowel diseases.
11
NY-ESO-1 or survivin expression in glioma represents viable targets for anticancer-directed T-cells for the biological therapy of patients with glioma.
12
Active research into biological therapy is also under way and vaccines, antibodies and inhibitors of growth factors are all being evaluated.
13
Surgery is not often used as a treatment because of the efficacy of chemotherapy, biological therapy, radiotherapy and hematopoietic stem cell transplantation.
14
In this new era of biological therapy, medications that precisely target the molecular mediators of inflammation are being developed at a rapid pace.
15
The Ulster team has developed the world's first biological therapy to target NLRP3 and proof of concept tests have shown it exhibits superior anti-inflammatory activity.
16
Finally, we drafted some recommendations for the treatment of patients refractory to anti-tumor necrosis factor, as well as for the possible optimization of biological therapy.
